Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Heart Rhythm|February 25, 2014
Persistent lone atrial fibrillation: clinicopathologic study of 19 casesDomenico Corradi, Sergio Callegari, Laura Manotti, et al.
The Journal of Biological Chemistry|January 11, 2007
Dramatic accumulation of triglycerides and precipitation of cardiac hemodynamic dysfunction during brief caloric restriction in transgenic myocardium expressing human calcium-independent phospholipase A2gammaDavid J Mancuso, Xianlin Han, Christopher M Jenkins, et al.
Heart Rhythm O2|November 8, 2023
Innate immune signaling in hearts and buccal mucosa cells of patients with arrhythmogenic cardiomyopathyCarlos Bueno-Beti, Alessandro Tafuni, Stephen P Chelko, et al.
Biorxiv : the Preprint Server for Biology|August 31, 2023
Innate Immune Signaling in Hearts and Buccal Mucosa Cells of Patients with Arrhythmogenic CardiomyopathyCarlos Bueto-Beni, Alessandro Tafuni, Stephen P Chelko, et al.
Heart Rhythm|October 23, 2012
End stage of arrhythmogenic cardiomyopathy with severe involvement of the interventricular septumMaartje Noorman, Judith A Groeneweg, Angeliki Asimaki, et al.
Science Translational Medicine|June 13, 2014
Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathyAngeliki Asimaki, Sudhir Kapoor, Eva Plovie, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Cardiac Hemorrhage Precedes Hypertension-induced Fibrosis in Plasminogen Activator Inhibitor-1 Deficient MiceAlex C Pettey, Sohei Ito, Michael K Franklin, et al.
Heart Rhythm|April 29, 2010
Desmin mutations as a cause of right ventricular heart failure affect the intercalated disksEllen Otten, Angeliki Asimaki, Alexander Maass, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Inhibition of Soluble Epoxide Hydrolase Reduces Inflammation and Myocardial Injury in Arrhythmogenic CardiomyopathyDipak Panigrahy, Abigail G Kelly, Weicang Wang, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|May 22, 2013
Reduced plakoglobin immunoreactivity in arrhythmogenic cardiomyopathy: methodological considerationsMaartje Noorman, Sara Hakim, Angeliki Asimaki, et al.
Pageof 12